^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MT-8421

    i
    Associations
    News

    Trials

    Company:
    Molecular Templates
    Drug class:
    CTLA4 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types (NCT06034860)
    Phase 1
    Molecular Templates, Inc.
    Recruiting
    Last update posted :
    05/01/2024
    Initiation :
    11/01/2023
    Primary completion :
    07/01/2026
    Completion :
    10/01/2026
    PD-L1 • MSI • PD-1
    |
    MSI-H/dMMR
    |
    Opdivo (nivolumab) • MT-8421